骨髓增生异常综合征修订国际预后积分系统（IPSS-R）相关资讯-临床研究进展，文献-MedSci.cn

全部 期刊论坛 资讯文献

为您找到相关结果约500个

Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomesand need for models beyond IPSS-R

The IPSS-R has prognostic impact in untreated patients with MDS del(5q)

Prognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes

next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

PATIENTS WITH IPSS-R INTERMEDIATE RISK CAN BE SEPARATED INTO THREE RISK GROUPS

Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS

AN IPSS-R CUTOFF POINT OF 3 STRATIFIED MYELODYSPLASTIC SYNDROMES PATIENTS INTO TWO RISK GROUPS

AN IPSS-R CUTOFF POINT OF 3 STRATIFIED CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS INTO TWO RISK GROUPS

An increased percentage of myeloid CD34+bone marrow cells stratifies intermediate IPSS-R myelodysplastic

BENEFIT OF HYPOMETHYLATING AGENTS COMPARED TO SUPPORTIVE CARE FOR HIGHER RISK MYELODYSPLASTIC SYNDROME BY IPSS-R

LYMPHOPENIA IS AN INDEPENDENT RISK-FACTOR IN PATIENTS WITH LOW-RISK MDS ACCORDING TO THE IPSS-R

usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R

System Design of E-Markets for IPSS Purchasing

CALCULATING IPSS-R BY ENUMERATING BONE MARROW BLASTS FROM NONERYTHROID CELLULARITY IMPROVES OUTCOME PREDICTION

is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk